JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares (ZJYL) Stock Price

ZJYLStock

$2.08−71.74%52W

Market Cap$155.31M

P/E108.70x

PEG Ratio1.79

Div yield—

Beta6.92

ZJYL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-19.86%

Price vs S&P 500 (4W)1.81%

PEG Ratio1.79

VGM Score31.40

P/E Ratio (Annual)108.70x

P/CF (Annual)44.60x

Book Value / Share (Quarterly)$3.79

P/TBV (Annual)3.10x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)2.53%

Cash Flow / Share (Quarterly)$-0.48

Price vs S&P 500 (YTD)-64.45%

Gross Margin (TTM)29.22%

Net Profit Margin (TTM)5.76%

EPS (TTM)$0.15

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$0.15

Revenue Growth (5Y)5.02%

EPS (Annual)$0.15

ROI (Annual)2.46%

Gross Margin (Annual)29.22%

Net Profit Margin (5Y Avg)12.54%

Cash / Share (Quarterly)$3.79

P/E Basic Excl Extra (TTM)108.70x

Revenue Growth QoQ (YoY)-16.53%

EPS Growth (5Y)61.62%

P/E Normalized (Annual)108.70x

ROA (Last FY)2.23%

Revenue Growth TTM (YoY)-11.98%

EBITD / Share (TTM)$0.11

ROE (5Y Avg)13.06%

Operating Margin (TTM)2.94%

Cash Flow / Share (Annual)$-0.48

P/B Ratio4.37x

P/B Ratio (Quarterly)2.98x

Net Income / Employee (Annual)$4,400

EV / Revenue (TTM)6.81x

Net Interest Coverage (TTM)19.82x

ROA (TTM)2.34%

EPS Growth QoQ (YoY)-31.95%

EV / EBITDA (TTM)165.42x

EPS Incl Extra (Annual)$0.15

Current Ratio (Annual)1.86x

Quick Ratio (Quarterly)1.50x

3-Month Avg Trading Volume0.52M

52-Week Price Return-71.74%

P/E Incl Extra (TTM)108.70x

Revenue / Employee (TTM)$75,800

Tangible BV / Share (Quarterly)$3.65

P/S Ratio (Annual)6.26x

Asset Turnover (Annual)0.39x

52-Week High$8.48

Operating Margin (5Y Avg)11.33%

EPS Excl Extra (Annual)$0.15

CapEx CAGR (5Y)115.61%

26-Week Price Return-9.95%

Quick Ratio (Annual)1.50x

13-Week Price Return9.48%

Total Debt / Equity (Annual)0.64x

Current Ratio (Quarterly)1.86x

Enterprise Value$140.87M

Revenue / Share Growth (5Y)92.03%

Asset Turnover (TTM)0.41x

Revenue / Employee (Annual)$75,800

Inventory Turnover (Annual)2.90x

Pretax Margin (Annual)7.71%

Cash / Share (Annual)$3.79

3-Month Return Std Dev118.33%

Gross Margin (5Y Avg)33.36%

Net Income / Employee (TTM)$4,400

EBITDA CAGR (5Y)-20.52%

ROE (Last FY)4.02%

EPS Basic Excl Extra (Annual)$0.15

P/FCF (TTM)253.46x

Receivables Turnover (TTM)2.88x

Total Debt / Equity (Quarterly)0.64x

EPS Incl Extra (TTM)$0.15

Receivables Turnover (Annual)2.88x

ROI (TTM)2.59%

P/S Ratio (TTM)6.26x

Pretax Margin (5Y Avg)13.99%

Revenue / Share (Annual)$2.64

Tangible BV / Share (Annual)$3.65

Price vs S&P 500 (52W)-87.27%

P/E Ratio (TTM)108.70x

EPS Growth TTM (YoY)-39.58%

Year-to-Date Return-52.73%

5-Day Price Return-5.45%

EPS Normalized (Annual)$0.15

ROA (5Y Avg)8.79%

Net Profit Margin (Annual)5.76%

Month-to-Date Return8.91%

EBITD / Share (Annual)$0.11

EPS Growth (3Y)108.05%

Operating Margin (Annual)2.94%

P/CF (TTM)44.60x

ROI (5Y Avg)11.68%

P/E Excl Extra (TTM)108.70x

EPS Basic Excl Extra (TTM)$0.15

P/TBV (Quarterly)3.10x

P/B Ratio (Annual)2.98x

Inventory Turnover (TTM)2.90x

Pretax Margin (TTM)7.71%

Book Value / Share (Annual)$3.79

Price vs S&P 500 (13W)6.79%

Net Margin Growth (5Y)-15.81%

Beta6.92x

P/FCF (Annual)43.27x

Revenue / Share (TTM)$2.64

ROE (TTM)4.14%

52-Week Low$1.53

vGradeF

gGradeD

mGradeC

vgmGradeD

Industry Peers — Orthopedic & Prosthetic Devices(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	F	D	C	6.3x	5.0%	29.2%	2.9%	$2.08
ISRGIntuitive Surgical Inc.	D	B	B	13.7x	18.2%	66.7%	31.3%	$426.70
EWEdwards Lifesciences Corp	D	C	B	7.7x	6.7%	77.8%	18.2%	$86.60
STESTERIS plc	C	C	B	3.6x	13.8%	44.4%	18.9%	$222.66
ZBHZimmer Biomet Holdings, Inc.	B	C	B	2.1x	3.2%	69.9%	14.2%	$94.98
SNNSmith & Nephew plc	B	C	C	1.9x	6.2%	68.2%	12.9%	$29.06
ALGNAlign Technology Inc	B	D	C	2.5x	10.3%	69.0%	13.2%	$147.31
MSAMine Safety Incorporated	C	C	B	3.5x	6.8%	47.6%	21.2%	$179.05
ESTAEstablishment Labs Holdings Inc.	F	A	C	7.2x	20.0%	70.5%	-7.6%	$59.18
ENOVEnovis Corporation	B	D	C	0.5x	-6.0%	61.4%	-45.1%	$19.59
CDRECadre Holdings, Inc.	B	C	C	1.6x	8.6%	41.8%	10.1%	$26.38
AVRAnteris Technologies Global Corp. Common Stock	D	C	C	263.0x	—	75.0%	-4738.4%	$6.05
SMTISanara MedTech Inc. Common Stock	D	C	B	2.8x	45.9%	93.0%	7.7%	$33.16
INGNInogen Inc	B	D	C	0.5x	2.5%	44.5%	-8.7%	$6.25
LAKELakeland Industries Inc	B	D	D	0.5x	3.9%	32.6%	-4.1%	$9.09
CNXUConexeu Sciences Inc. Common Stock	—	—	F	—	—	—	—	$3.06
NTRBNutriband Inc. Common Stock	F	D	B	46.7x	16.6%	33.1%	-435.6%	$6.22
SPAISafe Pro Group Inc. Common Stock	F	A	D	23.3x	—	62.2%	-513.8%	$3.30
APTAlpha Pro Tech, Ltd.	A	D	B	0.9x	-10.4%	37.5%	7.5%	$5.55
COCHEnvoy Medical, Inc. Class A Common Stock	F	F	C	249.8x	—	-385.5%	-11411.1%	$0.67
MYOMyomo Inc.	B	B	B	1.1x	40.1%	68.3%	-27.1%	$1.20
MLSSMilestone Scientific, Inc. Common Stock	D	C	C	3.1x	10.5%	70.2%	-43.6%	$0.33
LFWDLifeward Ltd. Ordinary Shares	A	C	C	1.1x	38.1%	32.9%	-125.5%	$6.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	F	196.5x	—	-0.4%	-9352.8%	$1.90
RGNTRegentis Biomaterials Ltd.	—	—	D	—	—	—	—	$1.49
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	D	F	C	17.6x	-17.3%	-147.6%	-3329.1%	$3.63
BBLGBone Biologics Corp Common Stock	—	—	F	—	—	—	—	$0.40
FEEDENvue Medical, Inc. Common Stock	—	F	F	0.2x	—	-26.1%	-1362.7%	$0.37
AVNSAvanos Medical, Inc.	B	D	B	1.6x	-0.4%	50.0%	-8.8%	$0.00
BBLGWBone Biologics Corp Warrants	—	—	D	—	—	—	—	$7.70
COCHWEnvoy Medical, Inc Warrant	—	—	D	—	—	—	—	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	—	—	—	—	$0.55

About JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares

Jin Medical International designs, manufactures, and distributes rehabilitation equipment, with wheelchairs as its primary revenue-generating product. The company's portfolio also includes oxygen concentrators, respiratory aids, and assistive living devices, served through dealer networks across Japan, China, North America, and other international markets. Japan represents the company's largest geographic market, with significant presence in China and other developed economies.